MINNEAPOLIS--(BUSINESS WIRE)--TripleTree, LLC, a strategic advisor and merchant bank serving innovative and market-leading companies in healthcare, is pleased to announce that it advised Intelligent Medical Objects (IMO) in its growth capital investment from Warburg Pincus. IMO is the market leading software and content provider of a rich set of Clinical Interface Terminology (CIT) products used by clinicians at the point of care to accurately capture, measure, and maintain the “true” clinical intent of the patient encounter as a means of driving activities across the entire care continuum. IMO presents an opportunity to enable and accelerate sophisticated analytics and decision support capabilities that improve care quality and address the next generation of challenges in healthcare.
“TripleTree’s healthcare expertise and deep understanding of the industry was an asset during the process, in particular in articulating IMO’s value proposition and broad impact to health systems and providers,” said Frank Naeymi-Rad, Chairman and CEO of IMO. “TripleTree ran a thorough process which resulted in several strategic options for our shareholders to consider. The outcome with Warburg Pincus positions IMO, our channel partners, and our customers, for the next chapter.”
“IMO delivers the foundational terminology platform to enable better communication between clinicians, patients, information technology and all downstream data users by bridging the gap between clinical language and complex coding systems. IMO’s exceptional market reputation emanates from its incredibly passionate and satisfied physician users,” said Brian Klemenhagen, Managing Director at TripleTree. “We look forward to IMO’s new partnership with Warburg Pincus as it continues to grow and support a growing number of health systems and providers.”
TripleTree acted as the exclusive financial advisor to IMO for this transaction.
TripleTree is an independent merchant bank focused on mergers and acquisitions, growth capital, recapitalizations, strategic advisory and principal investing. Since 1997, the firm has advised and invested in some of the most innovative, high-growth businesses in healthcare. For more, visit www.triple-tree.com.
Intelligent Medical Objects, Inc., (IMO) is the developer of the most widely-accepted medical terminology solution for the management of medical vocabularies and software applications at healthcare organizations worldwide. IMO's terminology is used by more than 3,500 hospitals and 450,000 physicians daily, and this trusted terminology platform supports innovations by provider systems. IMO medical vocabulary and mapping products effectively capture clinical intent and help EMRs preserve and communicate this across the entire spectrum of care. IMO clinical terms are mapped to all standard coding systems including ICD-9, ICD-10 and SNOMED®, The accuracy of IMO’s interface terminology was found to be ”nearly perfect” in an independent study published by the US Centers for Disease Control.